Tag: and Zambia

Zimbabwe Joins Rollout of First-Ever Oral Treatment for Deadly Sleeping Sickness

Michael Gwarisa

By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic regions like Zimbabwe, where tsetse fly infestations remain a concern. The new drug, Fexinidazole Winthrop, is now being offered free of charge in specialized treatment centres in Zimbabwe, Malawi, Ethiopia, Tanzania, and Zambia. Its approval…

Read More

Alcon Celebrates One Year of Advancing Eye Care Through its Phaco Development Program in Africa

Michael Gwarisa

By Michael Gwarisa Alcon, the global leader in eye care dedicated to helping people see brilliantly, today commemorated the first anniversary of its African Phaco Development Program (PD). This milestone reflects the program’s significant achievements across South Africa, Kenya, and Zambia, with plans for further regional expansion. Alcon remains committed to the principle of “Skill Africa, by Africa, for Africa,” as it continues to enhance healthcare capacity and improve access to eye care across the continent. According to the World Health Organization1, over 110 million people in Africa suffer from…

Read More

Zimbabwe Among 17 African Nations to Receive WHO and Africa CDC Support for Targeted Mpox Vaccine Rollout

Michael Gwarisa

By Michael Gwarisa Zimbabwe has been selected as one of 17 African countries to receive targeted support for mpox vaccine development, a major initiative spearheaded by the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC). The initiative aims to bolster vaccine preparedness and deployment efforts across the continent, with a focus on effectively reaching populations most at risk of mpox. Other countries benefiting from this support include Burundi, Cameroon, Central African Republic, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Ghana, Guinea, Liberia,…

Read More